Caraco Granted Tentative FDA Approval for Generic Version of Prandin

Monday afternoon, Caraco Pharmaceutical Laboratories Ltd. (CPD), a developer of generic prescriptions and over-the-counter pharmaceuticals, reported the receipt of tentative approval for its Abbreviated New Drug Application or ANDA for the 0.5mg, 1mg and 2mg doses of Repaglinide Tablets USP.
RTTNews